Citation Information :
Suri K, Rijhwani P, Gupta S, Jain M, Garg S, Agarwal P, Sarna M, Pahadia MR. Prevalence of Hemorrhagic Stroke Subtypes, Etiological Causes and Its Association with Various Stroke Related Risk Factors: An Observational Study. J Mahatma Gandhi Univ Med Sci Tech 2022; 7 (3):78-83.
Background: Hemorrhagic stroke (HS) is a significant cause of mortality and morbidity worldwide. This observational study aimed to determine the prevalence of HS subtypes and their association with various stroke-related risk factors.
Materials and methods: We conducted a prospective analysis of 38 patients diagnosed with HS at a tertiary health center in Rajasthan, India. We analyzed data related to demographic variables, clinical features, imaging findings, and risk factors related to HS.
Result: In our study, the male-to-female ratio was 5.3:1. The most common age-group affected by HS was 60–69 years. The incidence of intraparenchymal bleeding was 81.6%, and subarachnoid was 18.4%. Basal ganglia (50%) was the most frequent site of HS. Hypertension (HTN) was the most commonly associated risk-factor associated with HS. Chi-square analysis observed a significant association between HS and HTN (p = 0.041) and cardiovascular disease (CVD) (p = 0.005).
Conclusion: In our study, we observed a higher prevalence of HS in males and older adults. HTN was the most commonly associated modifiable risk-factor. Prompt identification and control of risk factors, particularly HTN, may help in the prevention and management of HS. More studies are needed to confirm the findings and explore the underlying mechanisms.
Warlow CP. Epidemiology of stroke. Lancet 1998;352(3):1–4. DOI: 10.1016/S0140-6736(98)90086-1
Sacco RL, Kasner SE, Broderick JP, et al. An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2013;44(7):2064–2089. DOI: 10.1161/STR.0b013e318296aeca
Hisham NF, Bayraktutan U. Epidemiology, pathophysiology, and treatment of hypertension in ischaemic stroke patients. J Stroke Cerebrovasc Dis 2013;22(7):e4–e14. DOI: 10.1016/j.jstrokecerebrovasdis.2012.05.001
Banerjee TK, Mukherjee CS, Sarkhel A. Stroke in the urban population of Calcutta: an epidemiological study. Neuroepidemiology 2001;20(3):201–207. DOI: 10.1159/000054788
Department of Health. Research. Annual report 2013–2014.
WHO. The global burden of disease: 2004 update. Geneva, Switzerland: WHO; 2008.
Renjen PN, Beg MA, Ahmad K. Epidemiological study of incidence and risk factors of Ischemic stroke subtypes according to Trial of ORG 10172 in acute stroke treatment criteria: a 3 years, hospital-based study. Int J Med Public Health 2015;5(1):50–54. DOI: 10.4103/2230-8598.151258
Chen R, Ovbiagele B, Feng W. Diabetes and stroke: epidemiology, pathophysiology, pharmaceuticals and outcomes. Am J Med Sci 2016;351(4):380–386. DOI: 10.1016/j.amjms.2016.01.011
Lee SH, Park KJ, Kang SH, et al. Prognostic factors of clinical outcomes in patients with spontaneous thalamic hemorrhage. Med Sci Monit 2015;21:2638–2646. DOI: 10.12659/MSM.894132
Siddique A, Nur Z, Mahbub S, et al. Clinical presentation and epidemiology of stroke: a study of 100 cases. J Med 2009;10(2):86. DOI: 10.3329/jom.v10i2.2820
Baidya OP, Chaudhuri S, Devi KG. Clinico-epidemiological study of acute ischemic stroke in a tertiary hospital of northeastern state of India. Int J Biomed Adv Res 2013;4(9):661. DOI: 10.7439/ijbar.v4i9.486
Hosaini SA, Bazrafshan H. A statistical study on the role of high-risk factors in the incidence of CVA. J Univ Med Sci 2001;3(2):76–80.
Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 2009;338:b1665. DOI: 10.1136/bmj.b1665
Taylor BC, Wilt TJ, Welch HG. Impact of diastolic and systolic blood pressure on mortality: implications for the definition of “normal”. J Gen Intern Med 2011;26(7):685–690. DOI: 10.1007/s11606-011-1660-6
Sturgeon JD, Folsom AR, Longstreth WT Jr, et al. Risk factors for intracerebral hemorrhage in a pooled prospective study. Stroke 2007;38(10):2718–2725. DOI: 10.1161/STROKEAHA.107.487090
Rodriguez BL, D’Agostino R, Abbott RD, et al. Risk of hospitalized stroke in men enrolled in the Honolulu heart program and the Framingham study: a comparison of incidence and risk factor effects. Stroke 2002;33(1):230–236. DOI: 10.1161/hs0102.101081
Tziomalos K, Athyros VG, Karagiannis A, et al. Dyslipidemia as a risk factor for ischemic stroke. Curr Top Med Chem 2009;9(14):1291–1297. DOI: 10.2174/156802609789869628
Arboix A, Massons J, García-Eroles L, et al. Diabetes is an independent risk factor for inhospital mortality from acute spontaneous intracerebral hemorrhage. Diabetes Care 2000;23(10):1527–1532. DOI: 10.2337/diacare.23.10.1527
Sarti C, Kaarisalo M, Tuomilehto J. The relationship between cholesterol and stroke. Implications for antihyperlipidaemic therapy in older patients. Drugs Aging 2000;17(1):33–51. DOI: 10.2165/00002512-200017010-00003
Roquer J, Rodríguez Campello A, Gomis M, et al. Serum lipid levels and in-hospital mortality in patients with intracerebral hemorrhage. Neurology 2005;65(8):1198–1200. DOI: 10.1212/01.wnl.0000180968.26242.4a
Cui R, Iso H, Toyoshima H, et al. Serum total cholesterol levels and risk of mortality from stroke and coronary heart disease in Japanese: the JACC study. Atherosclerosis 2007;194(2):415–420. DOI: 10.1016/j.atherosclerosis.2006.08.022
Hobeanu C, Lavallée PC, Charles H, et al. Risk of subsequent disabling or fatal stroke in patients with transient ischaemic attack or minor ischaemic stroke: an international, prospective cohort study. Lancet Neurol 2022;21(10):889–898. DOI: 10.1016/S1474-4422(22)00302-7
Eapen RP, Parikh JH, Patel NT. A study of clinical profile and risk factors of cerebrovascular stroke. Gujarat Med J 2009;64:48–54.
Donnan GA, McNeil JJ, Adena MA, et al. Smoking as a risk factor for cerebral ischaemia. Lancet 1989;2(8664):643–647. DOI: 10.1016/s0140-6736(89)90894-5
Feigin V, Parag V, Lawes CM, et al. Smoking and elevated blood pressure are the most important risk factors for subarachnoid hemorrhage in the Asia-Pacific region: an overview of 26 cohorts involving 306,620 participants. Stroke 2005;36(7):1360–1365. DOI: 10.1161/01.STR.0000170710.95689.41
Jamrozik K, Broadhurst RJ, Anderson CS, et al. The role of lifestyle factors in the etiology of stroke. A population-based case-control study in Perth, Western Australia. Stroke 1994;25(1):51–59. DOI: 10.1161/01.str.25.1.51
Qureshi AI, Tuhrim S, Broderick JP, et al. Spontaneous intracerebral hemorrhage. N Engl J Med 2001;344(19):1450–1460. DOI: 10.1056/NEJM200105103441907
Fonseca AC, Ferro JM. Drug abuse and stroke. Curr Neurol Neurosci Rep 2013;13(2):325. DOI: 10.1007/s11910-012-0325-0
Cahill DW, Knipp H, Mosser J. Intracranial hemorrhage with amphetamine abuse. Neurology 1981;31(8):1058–1059. DOI: 10.1212/wnl.31.8.1058-a
Nolte KB, Brass LM, Fletterick CF. Intracranial hemorrhage associated with cocaine abuse: a prospective autopsy study. Neurology 1996;46(5):1291–1296. DOI: 10.1212/wnl.46.5.1291
Benowitz NL. Cigarette smoking and cardiovascular disease: Pathophysiology and implications for treatment. Prog Cardiovasc Dis 2003;46(1):91–111. DOI: 10.1016/s0033-0620(03)00087-2
Koskinen LO, Blomstedt PC. Smoking and non-smoking tobacco as risk factors in subarachnoid haemorrhage. Acta Neurol Scand 2006;114(1):33–37. DOI: 10.1111/j.1600-0404.2006.00591.x
Kalimo H. Pathology and genetics: cerebrovascular disease. Basel (Switzerland): ISN Neuropath press; 2005. p. 95.
Sucker C, Hetzel GR, Grabensee B, et al. Amyloidosis and bleeding: pathophysiology, diagnosis, and therapy. Am J Kidney Dis 2006;47(6):947–955. DOI: 10.1053/j.ajkd.2006.03.036
Yen CC, Lo YK, Li JY, et al. Recurrent primary intracerebral hemorrhage: a hospital based study. Acta Neurol Taiwan 2007;16(2):74–80.
Steiner T, Rosand J, Diringer M. Intracerebral hemorrhage associated with oral anticoagulant therapy: current practices and unresolved questions. Stroke 2006;37(1):256–262. DOI: 10.1161/01.STR.0000196989.09900.f8
Gorelick PB, Weisman SM. Risk of hemorrhagic stroke with aspirin use: an update. Stroke 2005;36(8):1801–1807. DOI: 10.1161/01.STR.0000174189.81153.85
Biffi A, Halpin A, Towfighi A, et al. Aspirin and recurrent intracerebral hemorrhage in cerebral amyloid angiopathy. Neurology 2010;75(8):693–698. DOI: 10.1212/WNL.0b013e3181eee40f